Celecoxib Safe, Effective for Brucellosis-Associated Depression

This article originally appeared here.
Share this content:
Celecoxib Safe, Effective for Brucellosis-Associated Depression
Celecoxib Safe, Effective for Brucellosis-Associated Depression

FRIDAY, May 29, 2015 (HealthDay News) -- Celecoxib seems safe and effective for treatment of depression due to acute brucellosis, according to a study published online May 26 in the Journal of Clinical Pharmacy and Therapeutics.

Sara Jafari, M.D., from the Tehran University of Medical Sciences in Iran, and colleagues conducted a randomized trial involving 40 outpatients with depression due to brucellosis with a Hamilton Depression Rating Scale score (HDRS) <19. Participants were randomized to eight weeks of treatment with celecoxib or placebo as an adjunct to antibiotic therapy.

The researchers observed a significant effect for time × treatment interaction on the HDRS score in repeated-measures analysis (P < 0.001). At the study end there was a significantly greater response to treatment in the celecoxib versus placebo group (50 versus 0 percent; P < 0.001). There were no serious adverse events.

"Celecoxib is a safe and effective treatment for brucellosis-associated depression when compared with placebo," the authors write. "Celecoxib was associated with fast improvement in depressive symptoms, which makes this drug a potentially useful augmentative strategy in patients with brucellosis."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »